APM
ATRC icon

Avidity Partners Management’s AtriCure ATRC Stock Holding History

Avidity Partners Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-446,600
Closed -$24.9M – 98
2020
Q4 		$24.9M Buy
+446,600
New +$19.3M 0.81% 46

Other funds holding ATRC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avidity Partners Management's ATRC Position: Q1 2021 in Review

Avidity Partners Management sold out of AtriCure (ATRC) in Q1 2021, closing a stake of 446,600 shares — an estimated $24.9M sold.

Avidity Partners Management first reported a position in ATRC in Q4 2020 and held it in 1 quarter. The position peaked at $24.9M in Q4 2020. 191 funds tracked by Wall St. Rank hold ATRC as of Q1 2021.

  • Avidity Partners Management reported no remaining AtriCure position as of Q1 2021 after selling out during the quarter.
  • Avidity Partners Management sold 446,600 AtriCure shares in Q1 2021, an estimated $24.9M.
  • Avidity Partners Management first reported a position in AtriCure in Q4 2020 and held it in 1 quarter.
  • Avidity Partners Management's AtriCure position peaked at $24.9M in Q4 2020.
  • 191 funds tracked by Wall St. Rank held AtriCure as of Q1 2021.

Based on Avidity Partners Management's 13F filing for Q1 2021, filed 17 May 2021.